Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxonidine and Remote Conditioning in Ischemia Reperfusion Injury
NCT04479813Phase 4Completed
- Sponsor
- Royal Perth Hospital
- Start
- Jul 2015
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of moxonidine in ischemia-reperfusion injury (IRI), sponsored by Royal Perth Hospital. Started Jul 2015; status: completed.
02
Drugs
moxonidine
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT04479813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479813.